RNA interferences targeting the Fanconi anemia/BRCA pathway upstream genes reverse cisplatin resistance in drug-resistant lung cancer cells.
about
The association of genetic variations in DNA repair pathways with severe toxicities in NSCLC patients undergoing platinum-based chemotherapy.Co-inhibition of pol θ and HR genes efficiently synergize with cisplatin to suppress cisplatin-resistant lung cancer cells survival.Suppression of the FA pathway combined with CHK1 inhibitor hypersensitize lung cancer cells to gemcitabine.Knockdown of REV3 synergizes with ATR inhibition to promote apoptosis induced by cisplatin in lung cancer cells.The functional status of DNA repair pathways determines the sensitization effect to cisplatin in non-small cell lung cancer cells.
P2860
RNA interferences targeting the Fanconi anemia/BRCA pathway upstream genes reverse cisplatin resistance in drug-resistant lung cancer cells.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
RNA interferences targeting th ...... g-resistant lung cancer cells.
@en
type
label
RNA interferences targeting th ...... g-resistant lung cancer cells.
@en
prefLabel
RNA interferences targeting th ...... g-resistant lung cancer cells.
@en
P2093
P2860
P1476
RNA interferences targeting th ...... g-resistant lung cancer cells.
@en
P2093
Chun-Hua Dai
He-Guo Jiang
Yong-Chang Chen
P2860
P2888
P356
10.1186/S12929-015-0185-4
P577
2015-09-18T00:00:00Z
P5875
P6179
1043744553